FibroGen reported a GAAP loss of $155.945 million for 9M 2021, up 19.4% from $130.657 million in the previous year. Revenues increased by 96.5% to $218.766 million from $111.32 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept